INTRODUCTION
============

Health insurance claims contain diagnostic information and are a valuable data source for economic and epidemiological studies. However, 2 problems arise when researchers use health insurance claims for epidemiological studies: the need to ensure (1) the accuracy of diagnoses and (2) the accuracy of disease classification. The former is challenging because health insurance claims are essentially financial documents and not medical records. The latter derives from the fact that principal diagnoses are chosen rather arbitrarily when the coders are not properly trained.

To bypass these difficulties, studies attempting to evaluate the economic effects of smoking,^[@r01]^ walking,^[@r02]^ and health promotional activities^[@r03]^ have largely used per-capita health care cost, without disease classification. Some studies estimating disease-specific health care costs for diseases such as asthma^[@r04]^ and liver disease^[@r05]^ also used other data sources, including the Patient Survey (a one-day cross-sectional sampling survey conducted by the Japanese Ministry of Health, Labour & Welfare), to increase the accuracy of disease classification. Indeed, disease classification on health insurance claims was shown to be of questionable accuracy when compared with the Patient Survey even for a well-defined disease category like dialysis.^[@r06]^

Health insurance claims are widely used for epidemiological studies abroad, and foreign researchers have validated the accuracy of diagnoses in an empirical manner with more or less positive results. A Korean study reported 76% accuracy of acute myocardial infarction (AMI) diagnoses through matching with medical records.^[@r07]^ A Taiwan study reported 74.6% accuracy of diabetes diagnoses through a questionnaire survey to patients.^[@r08]^ Researchers in the United States reported even higher accuracy: 94.1% positive predictive value (PPV) for AMI diagnoses,^[@r09]^ 72.6% to 80.8% PPV for pneumonia,^[@r10]^ and 76.2% sensitivity and 93.3% specificity for hypertension.^[@r11]^ Some researchers went so far as to match cases with the cancer registry to validate diagnoses of malignancy.^[@r12]^

However, when researchers use health insurance claims classified by principal diagnoses, the second problem, ie, the accuracy of classification, is more important than the accuracy of diagnoses per se. There may also be systematic biases in classification, because some diseases are more likely to be chosen as principal diagnoses than others.^[@r13]^

Accuracy of diagnoses can only be validated empirically through matching with a gold standard such as medical records, but accuracy of disease classification can be evaluated statistically. If claims of the same disease category have the same values, accurate classification should yield uniform claims, ie, zero variance. In other words, accurate classification should maximize the intercategory variance while minimizing intracategory variance.

In this study, statistical analysis is used to evaluate the accuracy of classification by analyzing per-claim costs of outpatient claims. Per-claim cost is the amount of money charged for medical treatment and is written on the bottom line of a health insurance claim. Per-claim cost is expressed in points and can be converted into Japanese yen by multiplying by 10.

METHODS
=======

Theory
------

Disease-specific means and variance can be estimated from published frequency tables---without referring to microdata that are not readily available---by using an optimization program such as Excel Solver with the assumption of a particular distribution. If a normal distribution is assumed, as is usually the case, then the frequency tables must follow a normal distribution for the optimization program to yield good estimates. Per-claim costs of health insurance claims do not follow a normal distribution, as evidenced by the skewed distribution in the frequency tables; they follow a log-normal distribution.^[@r14]^ Therefore, the ranges of frequency tables were log-transformed to ensure normal distribution. The goodness-of-fit of the log-normal distribution was confirmed by the Kolmogorov-Smirnov test.

Data source
-----------

The data source was the National Health Insurance Medical Benefit Survey (NHIMBS), a sampling survey on health insurance claims submitted in May of the survey year. Japan's National Health Insurance covers the population that does not have regular employment, eg, the self-employed, retired, and part-time workers. The NHIBMS has been administered by the Ministry of Health, Labour & Welfare (MHLW), Bureau of Health Insurance, Department of Investigation every year since 1955. The reports include 24 summary tables and 11 raw output tables, which are distributed by the Central Federation of National Health Insurance. Summary tables from 1998 to 2005 and both summary and raw output tables from 2005 to 2007 are available from the Portal Site of Official Statistics of Japan, maintained by the Statistics Bureau, Ministry of Internal Affairs and Communications, with the collaboration of related ministries and agencies (<http://www.e-stat.go.jp>).

The NHIMBS is a survey of all insurers (1818 municipal governments and 165 National Health Insurance societies as of March 2007). Health insurance claims are sampled randomly by each insurer at a specified sampling proportion. The sampling proportion is approximately 1/500 for regular and elderly beneficiaries. Until 2002, elderly was defined as age 70 years or older, after which the threshold was raised gradually to 75 years in 2007. Elderly beneficiaries also include people 65 years or older with certain disabilities. The sampling proportion for retiree beneficiaries is 1/100.

Because health insurance claims are administrative data, the population of health insurance claims can be determined from monthly administrative reports compiled by the Central Federation of National Health Insurance ([www.kokuho.or.jp](http://www.kokuho.or.jp)). The exact population and sample size of outpatient claims, as well as the number of beneficiaries from which the data were derived, are shown in Table [1](#tbl01){ref-type="table"}. Thirteen years of data (1995--2007) were used because the same ICD10 classification (commonly referred to as the "119 classification"^[@r15]^) has been applied since 1995.

###### Data on beneficiaries and outpatient claims

         No. of beneficiaries^a^   No. of outpatient claims                                                                            
  ------ ------------------------- -------------------------- -------- -------- ------------ ---------- ------- ----------- ---------- -------
  1995   30 507                    4153                       8290     42 950   23 315 377   (47 572)   490.1   3 660 465   (36 707)   99.7
  1996   30 319                    4254                       8831     43 404   24 472 909   (49 297)   496.4   3 840 657   (36 303)   105.8
  1997   30 451                    4373                       9352     44 176   25 123 382   (48 647)   516.4   3 935 421   (39 472)   99.7
  1998   30 155                    4590                       9921     44 666   26 074 183   (52 711)   494.7   4 144 267   (41 694)   99.4
  1999   30 520                    4786                       10 542   45 848   27 134 887   (55 406)   489.7   4 315 181   (43 426)   99.4
  2000   30 710                    5140                       11 190   47 040   29 160 510   (59 429)   490.7   4 741 168   (47 450)   99.9
  2001   31 213                    5343                       12 396   48 952   30 485 879   (62 331)   489.1   4 949 316   (49 243)   100.5
  2002   31 460                    5531                       12 567   49 558   31 434 551   (63 893)   492.0   5 028 551   (50 398)   99.8
  2003   32 264                    6047                       12 591   50 902   32 250 061   (65 420)   493.0   5 463 517   (54 600)   100.1
  2004   32 691                    6795                       12 204   51 690   31 511 976   (64 424)   489.1   6 035 495   (60 264)   100.2
  2005   32 680                    7500                       11 730   51 910   32 192 705   (65 289)   493.1   6 949 882   (69 212)   100.4
  2006   32 340                    8190                       11 270   51 800   32 516 241   (65 900)   493.4   7 878 017   (78 171)   100.8
  2007   31 783                    8822                       10 819   51 424   32 368 390   (65 436)   494.7   8 727 709   (86 610)   100.8

^a^from monthly administrative reports compiled by the Central Federation of National Health Insurance.

^b^from National Health Insurance Medical Benefit Survey.

The representativeness of the data is believed to be satisfactory because the survey includes all insurers. However, some irregularities were observed for renal failures in 2000, as shown in Table [2](#tbl02){ref-type="table"}. Data in the genitourinary disease category of 2000 were modified according to the 1999 and 2001 data.

###### Distribution of claims of renal failure (ICD10:N00--19) by per-claim cost (%)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
         Sample size (sampling proportion)   Per-claim cost (yen)   Arithmetic\                                                                     
                                                                    mean                                                                            
  ------ ----------------------------------- ---------------------- ------------- ------ ------ ------ ------ ----- --------------- --------------- -----------------
  1995   211                                 138                    245           12.3   11.1   16.3   11.8   7.5   5.5             34.9            159 292

  1996   211                                 165                    211           14.1   9.1    17.0   10.5   7.7   5.3             35.6            163 785

  1997   193                                 162                    234           10.5   12.0   15.5   8.5    9.2   5.0             39.2            170 907

  1998   217                                 185                    267           10.5   9.5    19.8   9.2    7.9   5.7             36.7            168 703

  1999   193                                 212                    266           11.4   11.6   12.2   8.1    6.6   3.5             46.1            186 753

  2000   219                                 247                    287           13.8   10.3   17.8   8.6    7.5   ***27.0***^a^   ***14.5***^a^   ***94 008***^a^

  2001   219                                 240                    314           12.2   10.7   16.5   8.0    6.4   5.2             41.0            177 358

  2002   198                                 255                    270           13.7   9.4    14.6   5.7    6.6   3.4             46.5            189 810

  2003   194                                 269                    314           15.7   10.0   14.6   6.4    5.6   5.2             42.4            174 586

  2004   263                                 229                    362           11.1   11.1   14.1   7.3    6.7   4.0             45.7            174 838

  2005   248                                 289                    377           14.6   12.7   13.4   6.1    5.6   4.9             42.6            166 683

  2006   241                                 251                    399           14.4   13.6   14.7   5.2    4.1   4.1             43.8            173 836

  2007   227                                 260                    428           11.2   12.9   12.3   6.6    6.8   3.3             47.0            184 728
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^irregularities are shown in ***bold, italic font***.

source: National Health Insurance Medical Benefit Survey.

Estimation of means and standard deviations of log-transformed per-claim costs
------------------------------------------------------------------------------

To determine whether an observed distribution follows a certain distribution (such as a normal distribution), the Kolmogorov-Smirnov (KS) test is used. In this test, the maximum discrepancy between the 2 cumulative distributions, or KS value, is used as a test statistic. If the KS value is smaller than 1.63/√n, then one can assume that the observed distribution follows the certain distribution at *P* = 0.01.^[@r16]^

Because the NHIMBS provides only arithmetic means for per-claim costs, the means (m) and standard deviations (σ) of log-transformed per-claim costs were estimated from disease-specific frequency tables (Summary table 16-2) using Excel Solver, an add-in program for Microsoft Excel software.

For example, 25.1% of outpatient claims with a principal diagnosis of diabetes were in the range of 500 to 1000 yen per-claim in 2006. The range of 500 to 1000 yen was log-transformed to LN(500)--LN(1000) or 6.21 to 6.91 (LN, natural logarithm). If the log-transformed per-claim costs follow a normal distribution, the proportion of claims in this range is expressed with Excel functions as follows ("TRUE" in Excel functions denotes cumulative density functions; "FALSE" denotes probability density functions):$$+ \mathbf{NORMDIST}(6.91,\mathbf{m},\mathbf{\sigma},\mathbf{TRUE}) - \mathbf{NORMDIST}(6.21,\mathbf{m},\mathbf{\sigma},\mathbf{TRUE})$$

Frequency tables consist of 7 ranges (1--500, 500--1000, 1000--2000, 2000--3000, 3000--5000, 5000--10 000, and ≥10 000 yen per-claim). Let R*~k~* denote the cumulative proportion of claims in the frequency tables in the *k*th range (1 ≦ *k* ≦ 7) and E*~k~* denote the estimated cumulative proportion in the log-transformed *k*th range using formula \[[1](#e01){ref-type="disp-formula"}\]. Then, the KS value is expressed as follows:$$\left. {KS~value} = {MAX} \middle| R_{k} - E_{k} \right|$$

Optimal m and σ were obtained using Excel Solver to minimize the KS value of the formula \[[2](#e02){ref-type="disp-formula"}\] for all disease categories and years. The square of σ, σ^2^, gives the variance within a given disease category (hereafter referred to as intracategory variance).

Estimation of intercategory variances
-------------------------------------

Let n, m, and σ denote the number of claims, and the mean and standard deviation of per-claim costs, respectively, of an entire sample, and n*~k~*, m*~k~*, and σ*~k~* denote those of the *k*th disease category. The relationship between the entire sample and disease categories are expressed as follows:$$n*m = {\sum\limits_{k}n_{k}}*m_{k}$$ $$n*\sigma^{2} = {\sum\limits_{k}n_{k}}*\sigma_{k}{}^{2} + {\sum\limits_{k}n_{k}}*{(m_{k} - m)}^{2}$$

Formula \[[4](#e04){ref-type="disp-formula"}\] signifies the following relationship: $$\mathbf{all~variance} = \mathbf{intracategory~variance} + \mathbf{intercategory~variance}$$

Hence, intercategory variance was calculated using the second part of the right side of formula \[[4](#e04){ref-type="disp-formula"}\].

Extrapolation of sample size
----------------------------

The number of sampled claims was obtained from the raw output tables (Table 7-1 for regular, 7-2 for elderly, and 7-3 for retiree beneficiaries) of the NHIMBS. However, the number of claims from these 3 beneficiary categories cannot be summed because the sampling proportion is different (1/500 for regular and elderly beneficiaries and 1/100 for retiree beneficiaries). Hence, the number of claims for retiree beneficiaries was deflated by five to adjust for the difference in sampling proportion.

Calculation of means and variance of residual subcategories
-----------------------------------------------------------

The NHIMBS presents disease-specific data on all 19 major disease categories in ICD10 (I--XIX), plus some selected subcategories. For example, NHIMBS presents data on ophthalmic disease (VII), as well as on a subcategory---cataract (H25--26). From these data, a residual subcategory, "other ophthalmic diseases (H00--59 minus H25--26)", must be extrapolated to create a mutually exclusive disease classification. The means and variances of residual subcategories can be calculated using formula \[[4](#e04){ref-type="disp-formula"}\]. A total of 38 mutually exclusive disease categories were thus created. A subcategory, "renal failure", was merged with a major category, "genitourinary diseases", because of irregularities in the data.

RESULTS
=======

Table [3](#tbl03){ref-type="table"} illustrates how the optimal m and σ were obtained. The left frequency table presents an actual distribution of per-claim costs and the right frequency table presents a theoretical distribution when per-claim costs are log-transformed and assumed to follow a normal distribution with optimal m and σ minimizing the KS value.

###### Optimal means and standard deviations of log-transformed per-claim costs of outpatient claims

  Year   Per-claim cost from NHIMBS   LN(per-claim cost) optimized to minimize KS values                                                                                               
  ------ ---------------------------- ---------------------------------------------------- ------ ------ ----- ----- ----- ------ ------ ------ ------ ----- ----- ----- ------ ------ ------
  1995   24.0                         25.8                                                 25.8   11.3   8.3   3.7   1.2   24.0   26.0   26.0   10.9   8.1   4.1   1.0   0.30   6.91   0.98
  1996   22.5                         26.0                                                 26.4   12.0   8.3   3.6   1.2   22.2   26.2   26.9   11.3   8.4   4.1   0.9   0.34   6.95   0.96
  1997   22.2                         25.5                                                 27.0   12.2   8.2   3.5   1.3   22.1   26.1   26.9   11.3   8.4   4.2   0.9   0.47   6.95   0.96
  1998   24.3                         26.5                                                 27.8   10.6   6.6   2.9   1.3   24.0   27.3   26.6   10.6   7.4   3.4   0.7   0.68   6.88   0.94
  1999   25.5                         26.8                                                 27.4   9.8    6.3   2.8   1.3   25.6   27.5   26.0   10.1   7.0   3.2   0.6   0.70   6.84   0.95
  2000   25.3                         26.3                                                 27.8   10.3   6.6   3.1   0.7   24.7   27.6   26.5   10.3   7.1   3.2   0.6   0.64   6.85   0.94
  2001   26.2                         26.3                                                 27.0   10.2   6.5   2.8   1.1   25.6   27.4   26.0   10.1   7.1   3.2   0.6   0.56   6.84   0.95
  2002   28.0                         26.5                                                 27.1   9.3    5.6   2.4   1.0   27.2   28.1   25.5   9.6    6.4   2.7   0.5   0.78   6.78   0.94
  2003   29.5                         27.3                                                 25.6   8.9    5.3   2.3   1.0   29.7   27.7   24.4   9.0    6.0   2.6   0.5   0.61   6.73   0.96
  2004   30.9                         27.3                                                 24.8   8.6    5.0   2.2   1.1   30.8   27.6   23.9   8.8    5.9   2.6   0.5   0.71   6.70   0.97
  2005   31.1                         26.9                                                 24.6   8.8    5.2   2.3   1.1   31.3   27.2   23.5   8.7    5.9   2.7   0.5   0.56   6.69   0.99
  2006   32.0                         26.8                                                 24.4   8.5    5.0   2.2   1.1   31.8   27.4   23.4   8.6    5.8   2.6   0.5   0.60   6.68   0.98
  2007   32.3                         26.8                                                 23.8   8.6    5.0   2.3   1.2   31.8   27.1   23.3   8.6    5.9   2.7   0.5   0.66   6.68   0.99

NHIMBS: National Health Insurance Medical Benefit Survey.

KS value: Kolmogorov-Smirnov value; SD: standard deviation.

Table [4](#tbl04){ref-type="table"} shows the results of the KS test for goodness-of-fit. Overall, per-claim costs were shown to follow a log-normal distribution in 5 of 13 years (1995, 1996, 1997, 2001, and 2005). On a disease-specific level, a majority of disease categories were shown to follow log-normal distributions. Most notably, all disease categories followed a normal distribution in 1995 and 1996. Hypertension had the largest number of non-compatible years (11 out of 13 years), reflecting its large sample size, followed by genitourinary diseases (9 out of 13 years), including dialysis, which has an exceptionally high per-claim cost. The overall compatibility improved when hypertension and/or genitourinary diseases were excluded (shown as a reference in Table [4](#tbl04){ref-type="table"}). Without these 2 categories, per-claim costs were shown to follow a log-normal distribution in all 13 years.

###### Results of Kolmogorov-Smirnov (KS) test for goodness-of-fit (α = 0.01)

  Diagnostic categories                                    ICD 10             1995   1996   1997   1998   1999   2000   2001   2002   2003   2004   2005   2006   2007   No. of \*
  -------------------------------------------------------- ------------------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ -----------
  ALL                                                      ALL                                     \*     \*     \*            \*     \*     \*            \*     \*     8
   ALL except hypertension^b^                                                                                                                \*            \*     \*     3
   ALL except genitourinary diseases^b^                                                                          \*     \*     \*     \*                                 4
   ALL except hypertension and genitourinary diseases^b^                                                                                                                 0
  gastrointestinal infection                               A00--09                                                                                                       0
  tuberculosis                                             A15--19                                                                                                       0
  sexually transmitted disease                             A50--64                                                                                                       0
  other infectious diseases                                rest of A00--B99                                                                                              0
  malignant tumor                                          C00--97                                                                                         \*     \*     2
  nonmalignant tumor                                       D00--48                                                                                                       0
  hematopoietic diseases                                   D50--89                                                                                                       0
  diabetes                                                 E10--14                                                                                                       0
  other endocrine diseases                                 rest of E00--90                                       \*            \*                                        2
  schizophrenia                                            F20--29                                                                                                       0
  other psychiatric diseases                               rest of F00--99                                                                                               0
  neurological diseases                                    G00--99                                                                                         \*     \*     2
  cataract                                                 H25--26                                                                                         \*     \*     2
  other ophthalmic diseases                                rest of H00--59                                                                                               0
  diseases of the ear                                      H60--95                                                                                                       0
  hypertension                                             I10--15                          \*     \*     \*     \*     \*     \*     \*     \*     \*     \*     \*     11
  ischemic heart diseases                                  I20--25                                                                                         \*     \*     2
  cerebrovascular diseases                                 I60--69                                                                                         \*     \*     2
  other circulatory diseases                               rest of I00--99                                                                                               0
  acute upper respiratory infection                        J00--06                                                                                                       0
  pneumonia                                                J12--18                                                                                                       0
  acute bronchitis                                         J20--21                                                                                         \*     \*     2
  chronic sinusitis                                        J32                                                                                                           0
  chronic obstructive pulmonary diseases                   J40--44                                                                                         \*     \*     2
  asthma                                                   J45--46                                                                                                       0
  other respiratory diseases                               rest of J00--99                                                                                               0
  stomach and duodenal diseases                            K25--29                                                                                                       0
  liver diseases                                           K70--77                                                                                                       0
  other gastrointestinal diseases                          rest of K00--93                                                                                               0
  skin diseases                                            L00--99                                                                                                       0
  musculoskeletal diseases                                 M00--99                                                                                                       0
  genitourinary diseases                                   N00--99                                 \*     \*            \*     \*     \*     \*     \*     \*     \*     9
  pregnancy and delivery                                   O00--99                                                                                                       0
  perinatal conditions                                     P00--96                                                                                                       0
  congenital anomalies                                     Q00--99                                                                                                       0
  unspecified conditions                                   R00--99                                                                                                       0
  bone fractures                                           ^a^                                                                                                           0
  other injuries                                           rest of S00--T98                                                                                              0
                                                                                                                                                                         
  No. of \*                                                                   0      0      1      2      2      2      2      3      2      2      2      9      9       

\*: significantly different from normal distribution at confidence level 0.01.

^a^S02,12,22,32,42,52,62,72,82,92,T02,08,10,12.

^b^for reference.

Table [5](#tbl05){ref-type="table"} and [6](#tbl06){ref-type="table"} show the exponentiated m and σ (exp(m) and exp(σ)) or geometric means and standard ratio for all disease categories and years. Geometric means of per-claim costs have consistently decreased, which may reflect a reduction in drug costs due to increasing separation of dispensing and prescription. In contrast, the standard ratio remains constant, around 2.55 to 2.70, throughout the study period. It is noteworthy that the standard ratio of per-claim costs is close to the Napier constant (*e* = 2.718). If the geometric mean of per-claim costs is 1000 yen and the standard ratio is 2.7, one can assume that 68% of claims fall within the range of 1000/2.7 to 1000 \* 2.7, or 370 to 2700 yen.

###### Exponentiated optimal means of log-transformed per-claim costs (= geometric means; in Japanese yen)

                                           ICD10              1995         1996         1997         1998        1999        2000        2001        2002        2003        2004        2005        2006        2007
  ---------------------------------------- ------------------ ------------ ------------ ------------ ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -----------
  ALL                                      ALL                **1002.3**   **1041.4**   **1044.9**   **969.8**   **930.7**   **948.4**   **930.8**   **882.9**   **835.6**   **813.6**   **807.9**   **795.7**   **798.8**
  gastrointestinal infection               A00--09            681.4        689.8        715.5        668.7       620.5       662.7       665.6       622.8       695.9       631.6       630.2       577.1       614.4
  tuberculosis                             A15--19            1465.7       1798.0       1397.2       1465.6      1358.4      1403.6      1220.1      1295.5      1235.8      833.8       1306.1      1103.5      1248.9
  sexually transmitted disease             A50--64            859.6        1086.5       914.6        748.1       866.7       1242.9      1037.7      1043.9      866.1       806.2       898.4       802.6       769.3
  other infectious diseases                rest of A00--B99   739.7        756.3        844.2        820.5       823.5       756.3       763.7       735.9       696.3       674.7       710.0       709.9       699.5
  malignant tumor                          C00--97            2011.7       1917.1       1871.5       1620.5      1615.8      1454.0      1458.8      1462.0      1481.8      1431.5      1497.1      1382.0      1538.5
  nonmalignant tumor                       D00--48            1271.5       1313.7       1287.6       1242.0      1100.6      1091.9      1083.2      996.5       1205.6      1008.0      992.4       921.4       952.3
  hematopoietic diseases                   D50--89            998.7        936.0        1069.5       959.7       815.6       968.4       870.4       876.3       837.1       743.8       872.5       808.3       865.7
  diabetes                                 E10--14            1594.9       1583.5       1604.8       1448.8      1388.4      1424.3      1406.5      1372.5      1285.7      1264.8      1237.0      1285.1      1276.0
  other endocrine diseases                 rest of E00--90    1260.1       1406.5       1301.9       1177.8      1107.4      1104.8      1106.7      1072.2      1031.6      958.7       947.7       921.4       914.5
  schizophrenia                            F20--29            1338.1       1307.8       1237.5       1248.4      1205.9      1151.4      1256.1      1186.7      1160.6      1044.6      1033.1      1022.7      948.0
  other psychiatric diseases               rest of F00--99    1000.3       1063.3       1033.8       998.7       925.6       953.4       892.0       916.5       891.4       828.2       795.7       737.1       700.5
  neurological diseases                    G00--99            1017.4       1036.7       1077.2       945.5       872.7       923.5       925.2       756.4       779.9       752.3       777.3       759.4       733.4
  cataract                                 H25--26            535.5        530.5        544.6        519.2       524.3       537.8       533.4       495.8       500.6       469.0       477.7       517.7       520.2
  other ophthalmic diseases                rest of H00--59    574.7        602.4        588.5        594.1       594.8       586.7       585.1       555.7       568.3       551.5       563.0       537.8       528.9
  diseases of the ear                      H60--95            729.1        787.8        802.7        720.5       731.2       729.3       706.4       678.5       643.3       638.8       621.3       630.3       594.0
  hypertension                             I10--15            1308.8       1333.7       1359.9       1210.2      1184.2      1240.0      1236.8      1169.6      1065.2      989.7       986.8       975.4       947.0
  ischemic heart diseases                  I20--25            1517.1       1591.5       1556.4       1418.1      1327.3      1347.6      1274.3      1172.7      1077.9      1011.6      1024.4      1030.7      986.7
  cerebrovascular diseases                 I60--69            1711.2       1751.3       1796.6       1499.3      1334.6      1281.4      1166.9      1102.0      1009.7      936.3       950.4       961.7       902.3
  other circulatory diseases               rest of I00--99    1296.5       1336.1       1289.6       1203.0      1165.3      1173.3      1156.1      1000.4      939.9       904.0       906.8       875.6       905.0
  acute upper respiratory infection        J00--06            550.1        586.0        600.4        598.0       625.7       605.9       598.4       577.7       565.1       589.0       563.1       559.5       556.0
  pneumonia                                J12--18            1506.7       1941.8       1386.2       1243.8      1537.7      1488.0      1213.8      1363.6      1161.1      1194.6      1301.2      1295.7      1407.8
  acute bronchitis                         J20--21            691.0        740.3        771.2        714.9       720.4       708.9       703.7       633.0       660.2       669.0       645.8       608.9       614.6
  chronic sinusitis                        J32                729.9        774.3        795.0        765.2       741.0       741.9       685.5       700.7       637.4       601.4       658.1       587.9       603.6
  chronic obstructive pulmonary diseases   J40--44            859.2        965.3        1051.4       984.8       921.0       917.1       907.8       951.7       829.1       877.7       751.8       756.6       758.1
  asthma                                   J45--46            1105.8       1124.6       1104.3       1001.5      1020.9      969.2       975.3       853.1       830.6       865.4       810.9       761.4       778.7
  other respiratory diseases               rest of J00--99    660.9        735.6        704.0        668.5       626.7       632.9       614.2       605.8       563.2       600.0       533.5       605.8       596.5
  stomach and duodenal diseases            K25--29            1281.0       1263.6       1244.4       1176.1      1105.5      1127.7      1104.5      1052.7      969.6       937.6       955.2       942.9       915.9
  liver diseases                           K70--77            1573.4       1618.0       1526.6       1417.7      1398.7      1400.2      1384.9      1375.3      1425.5      1282.8      1240.5      1272.4      1252.9
  other gastrointestinal diseases          rest of K00--93    956.5        999.9        1010.9       898.7       857.9       882.7       895.3       827.0       723.5       689.4       697.9       718.0       704.2
  skin diseases                            L00--99            488.3        506.8        506.5        513.2       489.8       486.1       474.5       431.2       452.0       411.7       422.7       425.1       391.1
  musculoskeletal diseases                 M00--99            1195.7       1184.8       1203.1       1105.4      1059.4      1077.1      1044.4      937.9       934.6       899.8       915.8       883.3       885.4
  genitourinary diseases                   N00--99            1180.3       1217.2       1212.8       1121.6      1071.2      1032.3      1001.4      947.9       884.4       833.8       845.4       859.0       832.2
  pregnancy and delivery                   O00--99            859.0        963.1        980.9        923.5       927.2       992.5       850.1       793.2       861.5       831.3       958.3       857.2       947.4
  perinatal conditions                     P00--96            728.0        585.9        578.5        564.8       887.0       689.5       636.7       615.1       687.1       525.5       767.3       955.7       931.1
  congenital anomalies                     Q00--99            744.0        808.0        856.0        695.4       823.3       676.6       693.1       831.0       578.9       701.4       650.9       632.3       594.4
  unspecified conditions                   R00--99            780.8        715.0        731.0        746.6       723.9       745.5       733.8       635.4       631.1       641.2       652.1       698.1       703.3
  bone fractures                           ^a^                1219.3       1272.7       1250.0       1142.5      1247.7      1218.3      1115.7      1096.1      1096.3      979.9       1111.1      1108.7      1070.6
  other injuries                           rest of S00--T98   795.7        855.4        884.0        865.3       822.4       875.0       839.8       804.1       784.1       768.8       803.3       778.4       807.4

^a^S02,12,22,32,42,52,62,72,82,92,T02,08,10,12.

###### Exponentiated optimal standard deviations of log-transformed per-claim costs (= standard ratio)

                                           ICD10              1995       1996       1997       1998       1999       2000       2001       2002       2003       2004       2005       2006       2007
  ---------------------------------------- ------------------ ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------
  ALL                                      ALL                **2.67**   **2.60**   **2.61**   **2.56**   **2.58**   **2.55**   **2.58**   **2.56**   **2.62**   **2.64**   **2.68**   **2.67**   **2.70**
  gastrointestinal infection               A00--09            2.71       2.28       2.39       2.47       2.29       2.29       2.29       2.17       2.32       2.06       2.41       2.18       2.33
  tuberculosis                             A15--19            2.46       2.59       2.66       2.58       2.86       2.71       2.74       3.39       3.62       3.44       2.81       3.07       3.59
  sexually transmitted disease             A50--64            2.31       2.99       2.57       2.28       2.92       2.22       1.94       1.95       1.98       2.13       2.00       1.94       2.33
  other infectious diseases                rest of A00--B99   3.06       2.98       2.82       2.84       2.71       2.81       2.73       2.80       2.79       2.92       2.77       2.70       2.79
  malignant tumor                          C00--97            3.34       3.39       3.19       3.68       3.61       3.25       3.51       3.91       4.02       4.12       3.80       3.94       4.02
  nonmalignant tumor                       D00--48            3.03       3.21       3.22       3.15       3.35       3.06       3.20       3.22       3.06       3.24       3.18       2.92       3.38
  hematopoietic diseases                   D50--89            2.47       3.05       2.87       2.61       2.77       2.75       2.63       2.64       2.38       2.93       2.74       2.53       2.66
  diabetes                                 E10--14            2.38       2.29       2.32       2.30       2.38       2.26       2.29       2.26       2.30       2.26       2.28       2.20       2.21
  other endocrine diseases                 rest of E00--90    2.29       2.29       2.23       2.21       2.23       2.12       2.21       2.19       2.29       2.24       2.28       2.40       2.29
  schizophrenia                            F20--29            2.33       2.28       2.20       2.26       2.28       2.23       2.37       2.56       2.45       2.63       2.74       2.91       2.98
  other psychiatric diseases               rest of F00--99    2.30       2.31       2.21       2.34       2.23       2.17       2.28       2.32       2.31       2.27       2.44       2.48       2.54
  neurological diseases                    G00--99            2.87       2.97       3.03       2.79       2.95       2.82       3.09       3.21       3.09       3.17       3.42       3.20       3.39
  cataract                                 H25--26            2.13       2.15       2.03       2.05       2.04       2.05       2.02       1.97       1.99       2.07       2.12       1.95       1.97
  other ophthalmic diseases                rest of H00--59    1.97       1.87       1.95       1.87       1.79       1.87       1.86       1.90       1.84       1.86       1.85       1.91       1.93
  diseases of the ear                      H60--95            2.50       2.65       2.50       2.64       2.53       2.44       2.34       2.49       2.45       2.54       2.51       2.47       2.47
  hypertension                             I10--15            2.14       2.10       2.09       2.05       2.08       2.08       2.11       2.14       2.19       2.25       2.32       2.35       2.36
  ischemic heart diseases                  I20--25            2.37       2.36       2.31       2.15       2.36       2.35       2.55       2.49       2.69       2.59       2.80       2.82       2.75
  cerebrovascular diseases                 I60--69            2.51       2.37       2.44       2.54       2.63       2.70       2.70       2.87       3.04       3.15       3.14       3.04       3.20
  other circulatory diseases               rest of I00--99    2.60       2.61       2.53       2.67       2.57       2.59       2.69       2.64       2.79       2.78       2.78       2.91       2.88
  acute upper respiratory infection        J00--06            2.01       2.03       2.06       2.06       2.02       2.07       2.04       1.94       1.99       1.96       1.94       2.04       2.00
  pneumonia                                J12--18            2.73       2.58       2.49       2.85       2.94       2.58       2.70       2.83       2.92       2.72       2.97       2.73       2.71
  acute bronchitis                         J20--21            2.04       2.07       2.14       2.00       1.94       1.94       2.01       1.95       1.92       1.89       1.96       2.07       2.09
  chronic sinusitis                        J32                2.48       2.38       2.47       2.30       2.55       2.39       2.51       2.30       2.33       2.45       2.45       2.41       2.48
  chronic obstructive pulmonary diseases   J40--44            2.70       2.46       2.77       2.73       2.79       2.33       2.84       2.61       2.86       3.27       3.22       3.24       3.28
  asthma                                   J45--46            2.51       2.57       2.52       2.52       2.50       2.50       2.55       2.60       2.56       2.54       2.71       2.67       2.71
  other respiratory diseases               rest of J00--99    2.82       2.44       2.52       2.55       2.48       2.57       2.88       3.11       3.12       3.02       3.08       2.81       2.88
  stomach and duodenal diseases            K25--29            2.36       2.41       2.33       2.39       2.42       2.39       2.45       2.40       2.45       2.46       2.59       2.59       2.65
  liver diseases                           K70--77            2.45       2.43       2.40       2.39       2.45       2.51       2.41       2.35       2.56       2.53       2.73       2.48       2.46
  other gastrointestinal diseases          rest of K00--93    3.07       2.92       2.93       3.01       2.98       2.90       3.09       3.15       3.09       3.32       3.08       3.34       3.30
  skin diseases                            L00--99            2.71       2.54       2.48       2.32       2.32       2.31       2.39       2.32       2.25       2.33       2.39       2.33       2.43
  musculoskeletal diseases                 M00--99            2.53       2.51       2.48       2.49       2.52       2.55       2.53       2.51       2.42       2.47       2.45       2.50       2.50
  genitourinary diseases                   N00--99            3.46       3.52       3.56       3.59       3.92       3.89       3.86       3.79       3.84       4.55       4.50       3.87       4.55
  pregnancy and delivery                   O00--99            1.97       2.14       2.04       2.00       2.08       2.06       2.09       2.44       2.20       2.08       2.14       2.19       2.04
  perinatal conditions                     P00--96            2.81       3.72       2.72       1.90       2.29       2.40       1.97       3.04       1.78       2.40       2.90       2.43       2.35
  congenital anomalies                     Q00--99            2.63       3.54       2.73       3.24       4.23       3.27       3.10       2.67       3.70       2.68       3.20       2.24       3.60
  unspecified conditions                   R00--99            2.74       2.97       2.97       2.70       2.72       2.73       2.79       2.58       2.93       2.88       2.87       2.79       2.76
  bone fractures                           ^a^                2.74       2.74       2.60       2.66       2.71       2.61       2.96       2.68       2.58       2.71       2.70       2.63       2.81
  other injuries                           rest of S00--T98   2.38       2.31       2.28       2.17       2.32       2.33       2.47       2.29       2.21       2.31       2.27       2.33       2.39

^a^S02,12,22,32,42,52,62,72,82,92,T02,08,10,12.

Table [7](#tbl07){ref-type="table"} shows the consistent decline in interclass variance relative to overall variance: in 1995, intercategory variance was 19.5% of overall variance but declined to only 10% in 2007. This means that disease categories account for less than before in discriminating differences in per-claim costs; Figure [1](#fig01){ref-type="fig"} shoes the trend line (Y = −0.0065X + 0.1659, R^2^ = 0.901). The declining trend reversed in 2002, when hospitals and clinics were mandated to choose principal diagnoses; however, the reversal was only temporary and the declining trend appears consistent. In 2007, another reversal occurred, but it is too early to determine if it is temporary.

![Trend in %intercategory variance in overall variance of per-claim cost of outpatient claims](je-20-166-g001){#fig01}

###### Estimated variances of log-transformed per-claim costs

  ---------------------------------------------------------------------
  Year   Overall\   Intercategory\   Intracategory\   %intercategory\
         V (A)      V (B)            V                V (B/A)
  ------ ---------- ---------------- ---------------- -----------------
  1995   53 023     8692             44 472           19.5%

  1996   51 777     8315             44 595           18.6%

  1997   52 011     8094             43 767           18.5%

  1998   53 941     7064             47 376           14.9%

  1999   57 383     6789             50 860           13.3%

  2000   60 250     7440             53 551           13.9%

  2001   64 965     7623             58 774           13.0%

  2002   64 950     8162             59 730           13.7%

  2003   70 608     7285             63 281           11.5%

  2004   72 096     6873             67 171           10.2%

  2005   76 907     7028             70 856           9.9%

  2006   78 663     6876             71 910           9.6%

  2007   81 517     7635             76 409           10.0%
  ---------------------------------------------------------------------

V: variance.

DISCUSSION
==========

This study demonstrated a consistent decline in the intercategory variance of per-claim costs. If the difference in per-claim costs among disease categories is held constant, the declining intercategory variance can be interpreted as declining accuracy of classification or, in other words, increasing misclassification. Until 2001, disease classification was conducted rather arbitrarily, with no explicit criteria, by nonprofessionals at insurers. Starting in 2002, hospitals and clinics were required to specify principal diagnoses, which, it was hoped, would enhance the accuracy of classification. The change in classifiers did increase intercategory variance, as suggested by this author's previous study,^[@r17]^ but the effect was short-lived and does not appear to have altered the overall declining trend. This finding is sufficient to rebut the common claim that classification is accurate when doctors choose principal diagnoses.

The goodness-of-fit evaluated by the KS test revealed that all disease categories followed log-normal distributions in 1995 and 1996, but that the goodness-of-fit deteriorated year by year as more categories were evaluated that did not follow a log-normal distribution, as indicated by increasing KS values. At the same time, this study revealed that the standard ratio of per-claim costs remained stable and close to the Napier constant (2.718). This finding should prove to be a useful rule of thumb for analysis of health insurance claims: 68% of claims fall between 2.718 times and 2.718th of the geometric mean.

Then, what is the cause of the decline in accuracy? The most probable cause is the increasing number of diagnoses, as suggested by this author in 1996.^[@r13]^ The average number of diagnoses in a claim has consistently increased, as shown in Figure [2](#fig02){ref-type="fig"}. The increased intercategory variance in 2002 can be explained by the sudden reduction in the number of diagnoses due to the revised rule exempting diagnoses for inexpensive drugs. Whatever the causes, disease classification by principal diagnoses is becoming progressively less accurate in discriminating per-claim costs. With the rapid computerization of claims, there is a need for a statistical method that can objectively quantify all diagnoses. Such a method was described by this author in a previous study.^[@r18]^

![Trend in average number of diagnoses in an outpatient claim](je-20-166-g002){#fig02}
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